development pipeline

Attention: open in a new window. Print

NOXXON Pharma AG is a clinical stage biotechnology company focusing on the development of Spiegelmers for the treatment of inflammatory diseases and hematological disorders. The company has preclinical Spiegelmers in additional indications. Please click on the programs on the left or on the arrows below to learn further details about compounds in development.

Image